Vaxxinity Inc - Ordinary Shares - Class A
VAXX
Get informed when a big investor buys or sells
+ FollowMarket Cap$25.36K
Close$
$-0.08
80200% downside
Current Fair Value
80200% downsideOvervalued by 80200% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $25,357.00 |
|---|---|
| Enterprise Value | $10.16 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 3.78 |
| Outstanding Shares | 127,218,000 |
Return
| Return on Equity | -424.51% |
|---|---|
| Return on Assets | -128.34% |
| Return on Invested Capital | -214.00% |
Valuation & Multiples
| P/E Ratio | -0.4 |
|---|---|
| PEG | 0.9 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.18 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.49 |
| Debt to Equity | 1.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▲ 0.00% |
|---|---|
| Total Invested | $43 |
| Investors Holding | 1▲ 1.00% |
ESG Score
No data